304 related articles for article (PubMed ID: 9065415)
1. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction.
Knäuper V; Cowell S; Smith B; López-Otin C; O'Shea M; Morris H; Zardi L; Murphy G
J Biol Chem; 1997 Mar; 272(12):7608-16. PubMed ID: 9065415
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of human collagenase-3.
Knäuper V; López-Otin C; Smith B; Knight G; Murphy G
J Biol Chem; 1996 Jan; 271(3):1544-50. PubMed ID: 8576151
[TBL] [Abstract][Full Text] [Related]
3. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
4. Cellular activation of the 72 kDa type IV procollagenase/TIMP-2 complex.
Brown PD; Kleiner DE; Unsworth EJ; Stetler-Stevenson WG
Kidney Int; 1993 Jan; 43(1):163-70. PubMed ID: 8433556
[TBL] [Abstract][Full Text] [Related]
5. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
[TBL] [Abstract][Full Text] [Related]
7. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
Goldberg GI; Strongin A; Collier IE; Genrich LT; Marmer BL
J Biol Chem; 1992 Mar; 267(7):4583-91. PubMed ID: 1311314
[TBL] [Abstract][Full Text] [Related]
8. The catalytic domain of activated collagenase I (MMP-1) is absolutely required for interaction with its specific inhibitor, tissue inhibitor of metalloproteinases-1 (TIMP-1).
Vallon R; Müller R; Moosmayer D; Gerlach E; Angel P
Eur J Biochem; 1997 Feb; 244(1):81-8. PubMed ID: 9063449
[TBL] [Abstract][Full Text] [Related]
9. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G
J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).
Suzuki K; Enghild JJ; Morodomi T; Salvesen G; Nagase H
Biochemistry; 1990 Nov; 29(44):10261-70. PubMed ID: 2176865
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B.
O'Connell JP; Willenbrock F; Docherty AJ; Eaton D; Murphy G
J Biol Chem; 1994 May; 269(21):14967-73. PubMed ID: 8195131
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
Shimada T; Nakamura H; Ohuchi E; Fujii Y; Murakami Y; Sato H; Seiki M; Okada Y
Eur J Biochem; 1999 Jun; 262(3):907-14. PubMed ID: 10411655
[TBL] [Abstract][Full Text] [Related]
13. Direct activation of human neutrophil procollagenase by recombinant stromelysin.
Knäuper V; Wilhelm SM; Seperack PK; DeClerck YA; Langley KE; Osthues A; Tschesche H
Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):581-6. PubMed ID: 8240261
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.
DeClerck YA; Yean TD; Lu HS; Ting J; Langley KE
J Biol Chem; 1991 Feb; 266(6):3893-9. PubMed ID: 1847392
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY; Marmer BL; Grant GA; Goldberg GI
J Biol Chem; 1993 Jul; 268(19):14033-9. PubMed ID: 8314771
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.
Aimes RT; Quigley JP
J Biol Chem; 1995 Mar; 270(11):5872-6. PubMed ID: 7890717
[TBL] [Abstract][Full Text] [Related]
17. Fragmentation of human polymorphonuclear-leucocyte collagenase.
Knäuper V; Osthues A; DeClerck YA; Langley KE; Bläser J; Tschesche H
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):847-54. PubMed ID: 8489511
[TBL] [Abstract][Full Text] [Related]
18. Coordinate induction of collagenase-1, stromelysin-1 and urokinase plasminogen activator (uPA) by the 120-kDa cell-binding fibronectin fragment in fibrocartilaginous cells: uPA contributes to activation of procollagenase-1.
Hu B; Kapila YL; Buddhikot M; Shiga M; Kapila S
Matrix Biol; 2000 Dec; 19(7):657-69. PubMed ID: 11102755
[TBL] [Abstract][Full Text] [Related]
19. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.
Stetler-Stevenson WG; Krutzsch HC; Wacher MP; Margulies IM; Liotta LA
J Biol Chem; 1989 Jan; 264(3):1353-6. PubMed ID: 2536363
[TBL] [Abstract][Full Text] [Related]
20. The enzymatic evaluation of procollagenase and collagenase inhibitors in crude biological media.
Lefebvre V; Vaes G
Biochim Biophys Acta; 1989 Sep; 992(3):355-61. PubMed ID: 2550082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
